摘要
目的:评价Ahmed青光眼阀植入治疗难治性青光眼的临床效果和安全性。方法:将确诊的难治性青光眼患者18例(18眼),植入Ahmed青光眼阀,随访12mo,观察眼压、视力、并发症等。结果:眼压由术前的(55.50±19.47)mmHg下降到术后的(17.32±5.47)mmHg,2眼需抗青光眼药物辅助治疗;视力保持原水平者11眼,升高6眼,下降1眼;主要并发症是早期低眼压、一过性高眼压、浅前房、前房积血、引流管堵塞等。结论:在难治性青光眼手术中AGV植入占有不可忽视的一席之地,其疗效和安全性的确切评价需要更多的研究支持。
AIM： To evaluate the clinical effects and safety of Ahmed glaucoma valve （AGV） implantation for refractory glaucoma. METHODS： Eighteen cases （18 eyes） diagnosed with refractory glaucoma were implanted AGV, and followed up for 12 months. Intraocular pressure, visual acuity, and complications were observed.
RESULTS： Intraocular pressure was decreased to （17.32 ± 5.47） mmHg, compared to （55.50 ± 19.47） mmHg before operation. Two eyes needed auxiliary treatment with antiglaucoma drugs. Visual acuity was remained in 12 eyes, increased in 5 eyes and decreased in 1 eye. The main complications were early hypotony syndrome, temporary intraocular hypertension, shallow anterior chamber, anterior chamber hyphema, and tube obstruction, ect.
CONCLUSION： AGV implantation for treating refractory glaucoma is very important and needs more researches on its effects and safety.
出处
《国际眼科杂志》
CAS
2008年第8期1675-1676,共2页
International Eye Science
